Piper Sandler Reiterates Overweight Rating on Boston Scientific (BSX): 'We Expect the Stock Will Grind Higher'
Tweet Send to a Friend
Piper Sandler analyst Matt O\'Brien reiterated an Overweight rating and $95.00 price target on Boston Scientific (NYSE: BSX).The analyst said ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
